Q301--Germline Genetic Lab Testing Services_VHA_National Oncology Program
Award Notice Posted
- Solicitation number
- 36C10X22Q0164
- Agency
-
VA Strategic Acquisition Center Frederick
Headquarters, Department of Veterans Affairs
- Awarded
- to Fulgent Therapeutics LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36C10X22P0119 Federal contract award
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Veterans Affairs Strategic Acquisition Center in Frederick, Maryland announces the award of contract 36C10X22P0119 to Fulgent Therapeutics LLC for germline genetic lab testing services to support the VA National Oncology Program. Fulgent Therapeutics LLC has been awarded $2,055,624.99 to provide these lab testing services as identified by the NAICS code 621511. The solicitation associated with this award was 36C10X22Q0164 and the contract was awarded on September 27, 2022.
Notice text
Awarded contract 36C10X22P0119 to FULGENT THERAPEUTICS LLC for 2055624.99000000 on 2022-09-27.
Files
| File | Type | Posted |
|---|---|---|
| 36C10X22P0119_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Q301--Germline Genetic Lab Testing Services_VHA_National Oncology Program Amendment 0001 - Post Answers to Vendor Questions | Solicitation | |
| Q301--Germline Genetic Lab Testing Services_VHA_National Oncology Program | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity